Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cong Sun

Showing results (601-610 of 607) with videos related to

Pageof 61
Sort By:
You have reached the last page of results.This site can display upto 607 results.
Cancer Immunology Research|April 9, 2020
Verteporfin Inhibits PD-L1 through Autophagy and the STAT1-IRF1-TRIM28 Signaling Axis, Exerting Antitumor EfficacyJiyong Liang, Lulu Wang, Chao Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2022
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusionXiao Zhang, Junping Hong, Ling Zhong, et al.
Cell Host & Microbe|October 17, 2023
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBVCong Sun, Yin-Feng Kang, Xin-Yan Fang, et al.
Nature|June 18, 2025
R9AP is a common receptor for EBV infection in epithelial cells and B cellsYan Li, Hua Zhang, Cong Sun, et al.
Signal Transduction and Targeted Therapy|October 9, 2024
AXIN1 boosts antiviral response through IRF3 stabilization and induced phase separationDan-Ling Dai, Chu Xie, Lan-Yi Zhong, et al.
Cell Reports|April 19, 2018
ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast CancerPeijing Zhang, Zhenna Xiao, Shouyu Wang, et al.
Plos One|June 19, 2013
Genetic loci for retinal arteriolar microcirculationXueling Sim, Richard A Jensen, M Kamran Ikram, et al.
Pageof 61

Showing results (601-610 of 607) with videos related to

Sort By:
Pageof 61
You have reached the last page of results.This site can display upto 607 results.
Cancer Immunology Research|April 9, 2020
Verteporfin Inhibits PD-L1 through Autophagy and the STAT1-IRF1-TRIM28 Signaling Axis, Exerting Antitumor EfficacyJiyong Liang, Lulu Wang, Chao Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2022
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusionXiao Zhang, Junping Hong, Ling Zhong, et al.
Cell Host & Microbe|October 17, 2023
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBVCong Sun, Yin-Feng Kang, Xin-Yan Fang, et al.
Nature|June 18, 2025
R9AP is a common receptor for EBV infection in epithelial cells and B cellsYan Li, Hua Zhang, Cong Sun, et al.
Signal Transduction and Targeted Therapy|October 9, 2024
AXIN1 boosts antiviral response through IRF3 stabilization and induced phase separationDan-Ling Dai, Chu Xie, Lan-Yi Zhong, et al.
Cell Reports|April 19, 2018
ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast CancerPeijing Zhang, Zhenna Xiao, Shouyu Wang, et al.
Plos One|June 19, 2013
Genetic loci for retinal arteriolar microcirculationXueling Sim, Richard A Jensen, M Kamran Ikram, et al.
Pageof 61